Trial intelligence / Profile preview

KDX-0811 (Dexrazoxane) for Anthracycline Extravasation

NCT01596088Phase 2Completed

Sponsor
Kissei Pharmaceutical Co., Ltd.
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexrazoxane in Anthracycline extravasation, sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.

02

Drugs

dexrazoxane
03

Conditions

Anthracycline extravasation

Beyond the preview

Go deeper on NCT01596088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01596088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call